Xtx Topco LTD Bolt Biotherapeutics, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$0.4 - $0.62 $11,799 - $18,289	-29,499 Reduced 65.71%	15,392 $6,000
Q4 2024 Feb 13, 2025	BUY	$0.5 - $0.68 $22,445 - $30,525	44,891 New	44,891 $24,000
Q1 2024 May 13, 2024	SELL	$1.01 - $1.4 $6,389 - $8,856	-6,326 Reduced 33.03%	12,826 $17,000
Q4 2023 Feb 13, 2024	BUY	$0.85 - $1.12 $16,279 - $21,450	19,152 New	19,152 $21,000
Q2 2023 Aug 14, 2023	BUY	$1.27 - $1.95 $16,902 - $25,952	13,309 New	13,309 $17,000
Q1 2022 May 13, 2022	SELL	$2.74 - $4.82 $34,121 - $60,023	-12,453 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.19 - $13.97 $52,178 - $173,968	12,453 New	12,453 $61,000

683K

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $193M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.